JP2023011759A5 - - Google Patents

Download PDF

Info

Publication number
JP2023011759A5
JP2023011759A5 JP2022172687A JP2022172687A JP2023011759A5 JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5 JP 2022172687 A JP2022172687 A JP 2022172687A JP 2022172687 A JP2022172687 A JP 2022172687A JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022172687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023011759A (ja
Filing date
Publication date
Priority claimed from PCT/JP2020/028575 external-priority patent/WO2022018875A1/ja
Application filed filed Critical
Publication of JP2023011759A publication Critical patent/JP2023011759A/ja
Publication of JP2023011759A5 publication Critical patent/JP2023011759A5/ja
Pending legal-status Critical Current

Links

JP2022172687A 2020-07-22 2022-10-27 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 Pending JP2023011759A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2022538564 2020-07-22
PCT/JP2020/028575 WO2022018875A1 (ja) 2020-07-22 2020-07-22 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物
JP2022538564A JPWO2022018875A1 (enrdf_load_stackoverflow) 2020-07-22 2020-07-22
JP2021121960A JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021121960A Division JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Publications (2)

Publication Number Publication Date
JP2023011759A JP2023011759A (ja) 2023-01-24
JP2023011759A5 true JP2023011759A5 (enrdf_load_stackoverflow) 2024-08-07

Family

ID=79729374

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022538564A Pending JPWO2022018875A1 (enrdf_load_stackoverflow) 2020-07-22 2020-07-22
JP2021121960A Active JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物
JP2022172687A Pending JP2023011759A (ja) 2020-07-22 2022-10-27 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2022538564A Pending JPWO2022018875A1 (enrdf_load_stackoverflow) 2020-07-22 2020-07-22
JP2021121960A Active JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Country Status (3)

Country Link
JP (3) JPWO2022018875A1 (enrdf_load_stackoverflow)
KR (2) KR102550455B1 (enrdf_load_stackoverflow)
WO (1) WO2022018875A1 (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ789674A (en) 2020-01-10 2025-07-25 Immuneering Corp Mek inhibitors and therapeutic uses thereof
JP7268255B1 (ja) * 2021-07-21 2023-05-02 中外製薬株式会社 アリールアミド誘導体の製造方法
US20250262194A1 (en) * 2022-04-20 2025-08-21 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical for treating or preventing cancer
EP4551558A2 (en) * 2022-07-08 2025-05-14 Nested Therapeutics, Inc. Mitogen-activated protein kinase (mek) inhibitors
WO2025007811A1 (zh) * 2023-07-06 2025-01-09 成都华健未来科技有限公司 一类芳香酰胺类衍生物及其用途
WO2025063275A1 (ja) * 2023-09-21 2025-03-27 中外製薬株式会社 アリールアミド誘導体の製造方法
WO2025146040A1 (zh) * 2024-01-01 2025-07-10 华健未来(成都)科技股份有限公司 芳香酰肼类衍生物及其医药用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4931419B2 (ja) * 2003-09-19 2012-05-16 中外製薬株式会社 新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
JP4842137B2 (ja) * 2003-11-19 2011-12-21 アレイ バイオファーマ、インコーポレイテッド Mekのヘテロ環系阻害剤及びその使用方法
MY144232A (en) * 2004-07-26 2011-08-15 Chugai Pharmaceutical Co Ltd 5-substituted-2-phenylamino benzamides as mek inhibitors
AR059339A1 (es) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
EP2604260B1 (en) * 2010-08-10 2017-05-10 Shionogi&Co., Ltd. Novel heterocyclic derivatives and pharmaceutical composition containing same
US20130123255A1 (en) * 2011-11-10 2013-05-16 Chugai Seiyaku Kabushiki Kaisha Combination of a pi3k inhibitor and a mek inhibitor
JP2016034900A (ja) * 2012-11-26 2016-03-17 中外製薬株式会社 5−置換−2−フェニルアミノ−ベンズアミド類の製造方法
CN109988105A (zh) * 2014-01-27 2019-07-09 天津滨江药物研发有限公司 作为蛋白激酶抑制剂的氮杂环类化合物及其制备方法
CN105384738B (zh) * 2014-08-21 2017-08-29 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
AR121078A1 (es) 2020-01-22 2022-04-13 Chugai Pharmaceutical Co Ltd Derivados de arilamida con actividad antitumoral
EP4186506A4 (en) 2020-07-22 2024-08-07 Chugai Seiyaku Kabushiki Kaisha COMPOSITION CONTAINING AN ARYLAMIDE DERIVATIVE

Similar Documents

Publication Publication Date Title
JP2022068302A5 (enrdf_load_stackoverflow)
JP2022028828A5 (enrdf_load_stackoverflow)
JP2022025124A5 (enrdf_load_stackoverflow)
JP2021185136A5 (enrdf_load_stackoverflow)
JP2021169491A5 (enrdf_load_stackoverflow)
JP2024059739A5 (enrdf_load_stackoverflow)
JP2021028398A5 (enrdf_load_stackoverflow)
JP2024016014A5 (enrdf_load_stackoverflow)
JP2021038271A5 (enrdf_load_stackoverflow)
JP2023022224A5 (enrdf_load_stackoverflow)
JP2021151238A5 (enrdf_load_stackoverflow)
JP2023105131A5 (enrdf_load_stackoverflow)
JP2023085489A5 (enrdf_load_stackoverflow)
JP2020127428A5 (enrdf_load_stackoverflow)
JP2020042034A5 (enrdf_load_stackoverflow)
JP2022060295A5 (enrdf_load_stackoverflow)
JP2020120660A5 (enrdf_load_stackoverflow)
JP2021100406A5 (enrdf_load_stackoverflow)
JP2024112817A5 (enrdf_load_stackoverflow)
JP2023011759A5 (enrdf_load_stackoverflow)
JP2023085551A5 (enrdf_load_stackoverflow)
JP2020171301A5 (enrdf_load_stackoverflow)
JP2020141705A5 (enrdf_load_stackoverflow)
JP2022022379A5 (enrdf_load_stackoverflow)
JP2022122912A5 (enrdf_load_stackoverflow)